XNCR  valuation analysis

Name: Xencor, Inc
Description: Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 05, 2021
Market cap: $1.90B (1073rd)
Sales(TTM): $124.27M (1390th)
Earnings(TTM): -$50.07M (1224th)

FFER: 1.60 (why)
Actual price: $32.63
FFEThis is Xencor, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $20.43
Quantile: XNCR is expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
No notables found through heuristics.
Earnings / MarketCap
Xencor, Inc
"Biotechnology" industry
Sales / MarketCap
Xencor, Inc
"Biotechnology" industry
Book / MarketCap
Xencor, Inc
"Biotechnology" industry
Equity / Assets
Xencor, Inc
"Biotechnology" industry